| - SMTL ID
- 5xg9.1
- Ligands
- PENTAETHYLENE GLYCOL; 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80-HEPTACOSAOXADOOCTACONTAN-82-OL
- Polypeptides
- Unconventional myosin IB
- Oligo-state
- monomer
|
| - SMTL ID
- 5xg9.2
- Ligands
- 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE; 2,5,8,11,14,17,20,23,26,29,32,35,38,41,44,47,50,53,56,59,62,65,68,71,74,77,80-HEPTACOSAOXADOOCTACONTAN-82-OL
- Polypeptides
- Unconventional myosin IB
- Oligo-state
- monomer
|
| - SMTL ID
- 5xg9.3
- Ligands
- SULFATE ION; 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE
- Polypeptides
- Unconventional myosin IB
- Oligo-state
- monomer
|
| - SMTL ID
- 5xg9.4
- Ligands
- 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE
- Polypeptides
- Unconventional myosin IB
- Oligo-state
- monomer
|
| - SMTL ID
- 5xg9.5
- Ligands
- -
- Polypeptides
- Unconventional myosin IB
- Oligo-state
- monomer
|
| - SMTL ID
- 5xg9.6
- Ligands
- -
- Polypeptides
- Unconventional myosin IB
- Oligo-state
- monomer
|
| - SMTL ID
- 5xg9.7
- Ligands
- SULFATE ION; 1-(2-METHOXY-ETHOXY)-2-{2-[2-(2-METHOXY-ETHOXY]-ETHOXY}-ETHANE
- Polypeptides
- Unconventional myosin IB
- Oligo-state
- monomer
|
| - SMTL ID
- 5xg9.8
- Ligands
- -
- Polypeptides
- Unconventional myosin IB
- Oligo-state
- monomer
|